Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia.
about
DNA Damage and Repair in Schizophrenia and Autism: Implications for Cancer Comorbidity and BeyondGastrodiae Rhizoma (tiān má): a review of biological activity and antidepressant mechanismsThe effect of extract of ginkgo biloba addition to olanzapine on therapeutic effect and antioxidant enzyme levels in patients with schizophreniaProbing the in vitro cytotoxicity of the veterinary drug oxytetracyclineN-acetyl cysteine treatment rescues cognitive deficits induced by mitochondrial dysfunction in G72/G30 transgenic miceBioactive lipids in schizophrenia.Meta-analysis of oxidative stress in schizophrenia.Reduced antioxidant defense in early onset first-episode psychosis: a case-control study.Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients.Abnormal intracellular accumulation and extracellular Aβ deposition in idiopathic and Dup15q11.2-q13 autism spectrum disordersOxidative stress in schizophrenia: an integrated approach.Clozapine protects dopaminergic neurons from inflammation-induced damage by inhibiting microglial overactivation.Oxidative stress and level of antioxidant enzymes in drug-naive schizophrenics.Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility geneAnalysis of manganese superoxide dismutase (MnSOD: Ala-9Val) and glutathione peroxidase (GSH-Px: Pro 197 Leu) gene polymorphisms in mood disorders.Imbalanced free radicals and antioxidant defense systems in schizophrenia: a comparative studyAdenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia.Grape seeds proanthocyanidin extract as a hepatic-reno-protective agent against gibberellic acid induced oxidative stress and cellular alterations.Investigation of Dysregulation of Several MicroRNAs in Peripheral Blood of Schizophrenia PatientsProtective Effect of Antioxidants on Neuronal Dysfunction and Plasticity in Huntington's Disease.Testicular disorders induced by plant growth regulators: cellular protection with proanthocyanidins grape seeds extract.The use of proteomic biomarkers for improved diagnosis and stratification of schizophrenia patients.The role of reactive oxygen species and oxidative stress in carbon monoxide toxicity: an in-depth analysis.Lipid peroxidation in psychiatric illness: overview of clinical evidenceThe discovery and development of new potential antioxidant agents for the treatment of neurodegenerative diseases.Accelerated aging in schizophrenia patients: the potential role of oxidative stressRole of T helper lymphokines in the immune-inflammatory pathophysiology of schizophrenia: Systematic review and meta-analysis.Elevated plasma F2-isoprostane levels in schizophreniaEvaluation of Paraoxonase, Arylesterase and Malondialdehyde Levels in Schizophrenia Patients Taking Typical, Atypical and Combined Antipsychotic TreatmentPaliperidone regulates intracellular redox system in rat brain: Role of purine mechanism.Serum total oxidant and antioxidant status in earthquake survivors with post-traumatic stress disorder.Inflammation and schizophrenia: alterations in cytokine levels and perturbation in antioxidative defense systems.Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics.The effects of inhaled formaldehyde on oxidant and antioxidant systems of rat cerebellum during the postnatal development process.Pathophysiological role of nitric oxide and adrenomedullin in autism.Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors.Pro-oxidant activity of zuclopenthixol in vivo: differential effect of the drug on brain oxidative status of scopolamine-treated rats.Effects of antipsychotics and vitamin C on the formation of reactive oxygen species.Identification of the mitochondrial MSRB2 as a binding partner of LG72.
P2860
Q26743371-C8BC40DA-9605-40CA-9DC3-D07029F2236FQ27006845-806662E5-7A56-44DC-B659-2594BC523AF1Q28290520-FEF6DCD1-3BB4-43B0-86E9-E0AF64467F31Q28540688-344E9382-643C-4A4C-9AEE-58E6A3766514Q30504497-6626730B-D838-4C44-A7F2-E24D5148174FQ33246888-33A23C97-A298-4EFC-B479-3769BEDA3AA5Q33601360-AD2CD7A3-40D8-4800-A731-95174AE794E3Q33820188-59A149C9-17CF-4F62-A44A-C95973FE72E8Q33979025-A83E89EB-C5EA-43BB-A574-21799CEA0927Q34261556-46CBEC68-2075-4FFD-8073-8D729819E208Q34494844-DCEB5D6D-A1FE-4C1B-9AB1-5CCDBA3E35DEQ34631859-179EEE56-B570-47DC-AE4B-6227494C90F4Q34786239-31C888AC-FAF1-4B96-9FC2-4C6C658BC5D2Q35015897-EC59F84D-999F-40F4-B513-70CD92BA9196Q35099770-6D1CE396-DDCA-429B-A452-CDF1DF2D2C04Q35166850-6861FF8A-55A6-4598-B425-A5140916FC7CQ35609275-224B2A7D-DBA6-4997-9CE1-92BABC459830Q36508050-65C13FD2-DE19-4F7B-AB45-EC109CBA3CE3Q37039270-F8A03437-6C66-45C0-AF86-F2783A7BC72DQ37160621-A2EB549C-744C-4C26-B1A7-57E071685F67Q37607467-49DB3E4D-F30D-4870-B5B6-42B56DFD20DBQ37668249-A2E28638-B9BC-424C-AACE-77EB5639604FQ38170139-0530F389-4221-4AC8-9518-E478A8F6F954Q38207718-271206EF-49B8-46A9-B6A6-989AE9AF40F2Q38215504-50C0298E-919A-40E5-A47D-9CED80CCF8A0Q38233270-2350665C-CF26-48A7-B3D4-DCB07A764BC5Q38238756-CCE8804C-67CE-4FF9-973D-0CE9798D6C96Q38296243-12E7FB0E-5D21-4907-81A7-BD8ECFF93131Q39166267-EE0E5943-CCAB-4E05-B6D6-6C0F1B75BF26Q41602246-20B92F8D-9CFC-4663-887C-A160F8376850Q41644149-D71DDE1E-2873-4B33-BD48-ABCC815A3703Q41957175-5C2DFCC2-30C8-4639-823F-04B6C64326BFQ42285193-FBF01C9B-1AEF-4073-937B-73C7FF763820Q42627586-04CC5C46-E4CC-426A-A503-33A206587E95Q43215947-FE9FB3B8-A77E-46F2-B90D-7F25B852732BQ44310380-729B2CDB-E9C4-42BC-B74D-2B60068CC82BQ44773988-A0862B05-630C-4838-B952-679A5FBACE57Q45118088-BD4B4960-BC69-4CC1-8612-AC6331D3142CQ46090406-D7242E4D-5736-4D37-AEFC-EE04689C99D5Q46858770-07B9E9B2-3B90-4086-8BFA-CA77E0DD872B
P2860
Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Evidence that the activities o ...... ferent forms of schizophrenia.
@en
Evidence that the activities o ...... ferent forms of schizophrenia.
@nl
type
label
Evidence that the activities o ...... ferent forms of schizophrenia.
@en
Evidence that the activities o ...... ferent forms of schizophrenia.
@nl
prefLabel
Evidence that the activities o ...... ferent forms of schizophrenia.
@en
Evidence that the activities o ...... ferent forms of schizophrenia.
@nl
P2093
P2860
P356
P1433
P1476
Evidence that the activities o ...... ferent forms of schizophrenia.
@en
P2093
P2860
P2888
P356
10.1038/SJ.MP.4000789
P407
P577
2001-01-01T00:00:00Z